BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 33950550)

  • 1. The relationship between cannabis and schizophrenia: a genetically informed perspective.
    Johnson EC; Hatoum AS; Deak JD; Polimanti R; Murray RM; Edenberg HJ; Gelernter J; Di Forti M; Agrawal A
    Addiction; 2021 Nov; 116(11):3227-3234. PubMed ID: 33950550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic support of a causal relationship between cannabis use and educational attainment: a two-sample Mendelian randomization study of European ancestry.
    Chen D; Wang X; Huang T; Jia J
    Addiction; 2023 Apr; 118(4):698-710. PubMed ID: 36465060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization.
    Hatoum AS; Morrison CL; Colbert SMC; Winiger EA; Johnson EC; Agrawal A; Bogdan R
    Biol Psychiatry Glob Open Sci; 2021 Dec; 1(4):317-323. PubMed ID: 34235496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying causal associations between women's reproductive traits and risk of schizophrenia: a multivariate validated two-sample Mendelian randomization analysis.
    Sun W; Wu X; Yang H; Yuan S; Chen J; Fang Y; Zhang X
    BMC Psychiatry; 2024 Feb; 24(1):161. PubMed ID: 38395764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colocalization of association signals at nicotinic acetylcholine receptor genes between schizophrenia and smoking traits.
    Al-Soufi L; Costas J
    Drug Alcohol Depend; 2021 Mar; 220():108517. PubMed ID: 33454625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study.
    Zhang Y; Ni Y; Li L
    Drug Alcohol Depend; 2024 Jan; 254():111037. PubMed ID: 38016197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide identification of the shared genetic basis of cannabis and cigarette smoking and schizophrenia implicates NCAM1 and neuronal abnormality.
    Song W; Lin GN; Yu S; Zhao M
    Psychiatry Res; 2022 Apr; 310():114453. PubMed ID: 35235886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Mendelian randomization to explore the gateway hypothesis: possible causal effects of smoking initiation and alcohol consumption on substance use outcomes.
    Reed ZE; Wootton RE; Munafò MR
    Addiction; 2022 Mar; 117(3):741-750. PubMed ID: 34590374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a causal relationship between executive function and liability to mental health and substance use? A Mendelian randomization approach.
    Burton SMI; Sallis HM; Hatoum AS; Munafò MR; Reed ZE
    R Soc Open Sci; 2022 Dec; 9(12):220631. PubMed ID: 36533203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bipolar disorder and cannabis use: A bidirectional two-sample Mendelian randomization study.
    Jefsen OH; Speed M; Speed D; Østergaard SD
    Addict Biol; 2021 Nov; 26(6):e13030. PubMed ID: 33733564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetically informed study on the association of cannabis, alcohol, and tobacco smoking with suicide attempt.
    Orri M; Séguin JR; Castellanos-Ryan N; Tremblay RE; Côté SM; Turecki G; Geoffroy MC
    Mol Psychiatry; 2021 Sep; 26(9):5061-5070. PubMed ID: 32507850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the genetic and causal relationship between initiation or use of alcohol, caffeine, cannabis and nicotine.
    Chang LH; Ong JS; An J; Verweij KJH; Vink JM; Pasman J; Liu M; MacGregor S; Cornelis MC; Martin NG; Derks EM
    Drug Alcohol Depend; 2020 May; 210():107966. PubMed ID: 32276208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Liability to Cannabis Use Disorder and COVID-19 Hospitalization.
    Hatoum AS; Morrison CL; Winiger EA; Johnson EC; Agrawal A; Bogdan R
    medRxiv; 2020 Nov; ():. PubMed ID: 33236033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder.
    Brunette MF; Roth RM; Trask C; Khokhar JY; Ford JC; Park SH; Hickey SM; Zeffiro T; Xie H
    Schizophr Bull; 2024 Jun; ():. PubMed ID: 38900958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The causal relationships of device-measured physical activity with bipolar disorder and schizophrenia in adults: A 2-Sample mendelian randomization study.
    Sun H; Gao X; Que X; Liu L; Ma J; He S; Gao Q; Wang T
    J Affect Disord; 2020 Feb; 263():598-604. PubMed ID: 31780129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating causality between liability to ADHD and substance use, and liability to substance use and ADHD risk, using Mendelian randomization.
    Treur JL; Demontis D; Smith GD; Sallis H; Richardson TG; Wiers RW; Børglum AD; Verweij KJH; Munafò MR
    Addict Biol; 2021 Jan; 26(1):e12849. PubMed ID: 31733098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study.
    Baumeister SE; Baurecht H; Nolde M; Alayash Z; Gläser S; Johansson M; Amos CI; ; Johnson EC; Hung RJ
    J Thorac Oncol; 2021 Jul; 16(7):1127-1135. PubMed ID: 33852959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating causal associations between use of nicotine, alcohol, caffeine and cannabis: a two-sample bidirectional Mendelian randomization study.
    Verweij KJH; Treur JL; Vink JM
    Addiction; 2018 Jul; 113(7):1333-1338. PubMed ID: 29334416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal associations between genetically determined common psychiatric disorders and the risk of falls: evidence from Mendelian randomization.
    Zhang H; Xu C; Yuan C; Shi B; Zhu W; Wang H; Fu F; Tang D; Wang Y
    Eur J Med Res; 2023 Dec; 28(1):578. PubMed ID: 38071363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking.
    Johnson EC; Austin-Zimmerman I; Thorpe HHA; Levey DF; Baranger DAA; Colbert SMC; Demontis D; Khokhar JY; Davis LK; Edenberg HJ; Di Forti M; Sanchez-Roige S; Gelernter J; Agrawal A
    Neuropsychopharmacology; 2024 Jun; ():. PubMed ID: 38906991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.